Your optimal choice depends on your primary goals, tolerance for side effects, existing health conditions, and whether you are using hormone replacement therapy concurrently
Phase 3 TRIUMPH-4 topline results have also been positive, showing substantial weight loss and additional benefits in adults with conditions such as overweight or obesity
Monitoring recommendations For topical users, formal monitoring isn't typically necessary
As part of the inquiry, the MHRA has partnered with Genomics England to launch a genetic study aimed at identifying whether some individuals have a genetic predisposition to developing pancreatitis after taking GLP-1 drugs
This means it is needed to preserve muscle tissue during dieting and exercise
A synergistic action in which glucagon receptor activation enhances energy expenditure whilst GLP-1 receptor agonists reduce calorie intake and both GLP-1/GIP potentiate the incretin effect to modulate the diabetogenic effect of glucagon agonists